5-氯-2-氟碘苯 | 116272-42-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-氯-2-氟碘苯
• 英文名称: 4-chloro-1-fluoro-2-iodobenzene
• CAS: 116272-42-5
• 化学式: C₆H₃ClFI
• 分子量: 256.446
• InChiKey: CNJQPBYTHITJAO-UHFFFAOYSA-N

物化性质

• 沸点：
  214 °C
• 密度：
  2.008±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• 海关编码：
  2903999090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
5-Chloro-2-fluoroiodobenzene
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H301: Toxic if swallowed
H319: Causes serious eye irritation
P301+P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Chloro-2-fluoroiodobenzene
CAS number: 116272-42-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
This product should be handled only by, or under the close supervision of, those properly qualified
Handling:
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H3ClFI
Molecular weight: 256.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen fluoride, hydrogen Iodide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (5-Chloro-2-fluoroiodobenzene)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-氯-2-氟碘苯 在 bis-triphenylphosphine-palladium(II) chloride 、 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 copper(l) iodide 、 二(三苯基膦)环戊二烯基氯化钌(II) 、 sodium carbonate 、 三乙胺 作用下， 以 1,4-二氧六环 、 水 、 甲苯 为溶剂， 反应 35.0h， 生成
  参考文献：
  名称：

  ALK5 INHIBITORS

  摘要：

  本公开提供抑制活性素受体样激酶5（ALK5）的抑制剂。还公开了调节ALK5活性的方法以及治疗由ALK5介导的疾病的方法。

  公开号：

  US20200188370A1
• 作为产物：
  描述：

  2-碘-4-氯苯胺 在 氟硼酸钠 、 sodium nitrite 作用下， 生成 5-氯-2-氟碘苯
  参考文献：
  名称：

  Synthesis of 2,4-dihalogenofluorobenzenes and their antimicrobial and antifungal activity studies

  摘要：

  The aim of this study was to synthesize and identify 2,4-dihalogenofluorobenzene (or trihalogenobenzene) derivatives by spectroscopic means, H-1-NMR and F-19-NMR. The 2,4-dihalofluorobenzene derivatives considered were 2,4-dichlorofluorobenzene (1), 2-bromo-4-chlorofluorobenzene (2), 2-iodo-4-chlorofluorobenzene(3), 2,5-dichlorofluorobenzene (4), 2-bromo-5-chlorofluorobenzene (5), 2-iodo-5-chlorofluorobenzene (6).The in vitro antibacterial and antifungal activities of trihalogenobenzene derivatives were studied against the bacteria Staphylococcus aureus ATCC 25923 Gram(+), Bacillus cereus ATCC 6633 Gram(+), Micrococcus flavus (clinical isolate) Gram(+), Morgenella morganii (clinical isolate) Gram(-), Escherichia coli ATCC 27853 Gram(-) and fungus Candida albicans (clinical isolate), obtained from the biology departments of the Pamukkale and Gazi Universities. The antibacterial and antifungal activities were measured by minimum inhibition concentration (MIC) method and the disc-diffusion method used to measure zone diameter against Gram-positive and Gram-negative bacteria and fungi. All these bacteria and fungi were studied against antibiotics to compare the zone diameters with the results from our treatments.

  DOI：

  10.1007/s00044-007-9024-9

文献信息

• HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
  申请人：LG CHEM, LTD.

  公开号：US20210139469A1

  公开（公告）日：2021-05-13

  A novel heterocyclic compound of Chemical Formula 1 and an organic light emitting device including the same. wherein one of Ar 1 to Ar 3 is of the following Chemical Formula 2, and one of Ar 4 to Ar 7 is a substituted or unsubstituted dibenzofuran; or a substituted or unsubstituted dibenzothiophene, the rest being hydrogen.

  化学式1的新型杂环化合物及包括该化合物的有机发光器件。 其中Ar1至Ar3中的一个为以下化学式2， Ar4至Ar7中的一个为取代或未取代的二苯并呋喃；或取代或未取代的二苯并噻吩，其余为氢。
• Palladium-Catalyzed Site-Selective Benzocylization of Aromatic Acids with <i>o</i>-Fluoro-Substituted Diaryliodonium Salts toward 3,4-Benzocoumarins
  作者：Cheng Pan、Limin Wang、Jianwei Han

  DOI：10.1021/acs.orglett.0c01577

  日期：2020.6.19

  By using 2-fluoro-substituted diaryliodonium salts, a novel benzocylization has been accomplished for the synthesis of 3,4-benzocoumarin derivatives via a cascade of ortho-arylation and defluorination in the presence of palladium catalysts. The reaction exhibits a broad compatibility of readily available aromatic acids with an excellent level of site-selectivity. Mechanistic investigations revealed

  通过用2-氟取代的二芳基碘盐，一种新颖的benzocylization已经完成用于经由级联的3,4-苯并香豆素衍生物合成邻-arylation和脱氟中的钯催化剂的存在下进行。该反应表现出容易获得的芳族酸的广泛相容性以及极好的位点选择性。机理研究表明，在本系统中，通过芳族氟化物的亲核取代，羧酸定向芳基化具有独特的反应性。
• Chemical Compounds
  申请人：Pfizer Limited

  公开号：US20140171435A1

  公开（公告）日：2014-06-19

  The present invention relates to imidazopyridazine derivatives. More particularly, it relates to 4-(biphenyl-3-yl)-7H-imidazo[4,5-c]pyridazine derivatives of formula (I): and pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the description. The imidazopyridazine derivatives of the present invention modulate the activity of the GABA A receptor. They are useful in the treatment of a number of conditions, including pain.

  本发明涉及咪唑吡啶并嗪衍生物。更具体地，涉及式(I)的4-(联苯基-3-基)-7H-咪唑并嗪衍生物及其药学上可接受的盐，其中R1、R2、R3、R4和R5如描述中所定义。本发明的咪唑吡啶并嗪衍生物调节GABA A 受体的活性。它们在治疗多种疾病，包括疼痛方面具有用处。
• [EN] TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS<br/>[FR] TRIAZA-SPIRODÉCANONES UTILISÉES EN TANT QU'INHIBITEURS DE DDR1
  申请人：HOFFMANN LA ROCHE

  公开号：WO2017005583A1

  公开（公告）日：2017-01-12

  The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein L and R1 to R5 are as described herein, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.

  本发明涉及式(I)的化合物或其药用盐，其中L和R1至R5如本文所述，以及它们的制备方法、包含它们的药物组合物，以及它们作为药物的用途。
• Palladium-Catalyzed Carbonylative Four-Component Synthesis of Thiochromenones: The Advantages of a Reagent Capsule
  作者：Chaoren Shen、Anke Spannenberg、Xiao-Feng Wu

  DOI：10.1002/anie.201600953

  日期：2016.4.11

  reactions, especially those involving four or even more reagents, have been a long‐standing challenge because of the issues associated with balancing reactivity, selectivity, and compatibility. Herein, we demonstrate how the use of a reagent capsule provides straightforward access to synthetically valuable thiochromenone derivatives by a palladium‐catalyzed carbonylative four‐component reaction. To the

  由于涉及平衡反应性，选择性和相容性的问题，多组分反应（尤其是涉及四种甚至更多种试剂的反应）一直是一项长期挑战。本文中，我们证明了使用试剂胶囊如何通过钯催化的羰基化四组分反应直接获得具有合成价值的硫代色酮衍生物。据我们所知，这是使用胶囊防止催化剂中毒和多组分反应不良反应的第一个例子。